PENIS GROWTH RESPONSE TO HORMONAL THERAPY IN CHILDREN WITH MICROPENIS AT HASAN SADIKIN HOSPITAL
##plugins.themes.bootstrap3.article.main##
##plugins.themes.bootstrap3.article.sidebar##
Abstract
Objective: This study aims to determine the response of penis growth to testosterone injection. Material & Methods: The study was conducted on all cases of micropenis from January 2016 to December 2020. Each subject who met the criteria for micropenis received 25 mg of intramuscular testosterone ester injection, in 4 doses with an interval of 1 week. Evaluation is done at the beginning, before administration of testosterone, then an evaluation is carried out for each patient before testosterone injection until 1 week after the 4th injection. Penis measurement is done by fully stretched length measurement. Results: There were 62 patients who met the criteria for micropenis. The average age of patients with micropenis when they first came was 5.9 years. The patient's mean initial penile length was 2.13 cm. There was an increase in penis length of 32% in the first injection, 28% after the second injection, 18% after the third injection and 14% after the fourth injection. The average length of the penis at the first, second, third and fourth injections was 2.53 cm, 3.24 cm, 3.65 cm and 4.01 cm, respectively. At the end of treatment, there was an average increase in penile length of 75.8% compared to the beginning of treatment. Conclusion: In conclusion, it can be said that testosterone therapy in micropenis patients gave a good response in terms of increasing penile length by 75.8% and increasing the average from 2.13 cm to 4.01 cm.
##plugins.themes.bootstrap3.article.details##
Micropenis, testosterone, growth
Kayes O, Chandra L, Yates A. Micropenis and penile dysmorphobia: diagnosis, management, outcomes, and future developments in the field. In: Male Sexual Dysfunction; 2016.
Alsaleem M, Saadeh L. Micropenis. StatPearls. Treasure Island (FL): StatPearls Publishing; 2017.
Lee PA, Mazur T, Danish R, et al. Micropenis. I. Criteria, etiologies and classification. Johns Hopkins Med J. 1980; 146(4): 156-63.
Hakimi H, Siregar CD, Deliana M. Prevalensi Mikropenis pada Murid Taman Kanak - Kanak. Sari Pediatr. 2004; 6(3): 115-8.
Tekgül S, Dogan HS, Hoebeke P, et al. EAU guidelines on paediatric urology. Eur Urol. 2016; 136.
Wallad, C., & Sibarani, J. Normative data of penile length on children age groups with tanner classification in Hasan Sadikin hospital. Bju International. 2014; 114.
Supriatmo, Siregar CD. Mikropenis. Sari Pediatr. 2016; 5(4): 145-149.
Akin Y, Ercan O, Telatar B, Tarhan F. Penile size in term newborn infants. Turk J Pediatr. 2011; 53(3): 301-7.
Akura B, Sacharina N. Mikropenis. Seputar Kesehatan Anak - IDAI. 2015.
Bin-Abbas B, Conte FA, Grumbach MM, Kaplan SL. Congenital hypogonadotropic hypogonadism and micropenis: Effect of testosterone treatment on adult penile size - Why sex reversal is not indicated. J Pediatr. 1999; 3476(99): 70244-1
Nerli RB, Guntaka AK, Patne PB, Hiremath MB. Penile growth in response to hormone treatment in children with micropenis. Indian J Urol. 2013; 29(4): 288-91.
Tridjaja B, Batubara JR, Pulungan A. Pengobatan Testosteron pada Mikropenis. Sari Pediatr. 2016.
Hatipoǧlu N, Kurtoǧlu S. Micropenis: Etiology, diagnosis and treatment approaches. JCRPE J Clin Res Pediatr Endocrinol. 2013; 5(4): 217-223.